LeMaitre Vascular Inc (NASDAQ:LMAT)
| 54.95 Delayed Data As of Aug 08 |  +1.71 / +3.21%Today’s Change | 38.32 Today|||52-Week Range 60.79 | +9.40% Year-to-Date |
Latest LMAT News | Press Releases
| ZBH vs. LMAT: Which Stock Should Value Investors Buy Now? Aug 05 / Zacks.com - Paid Partner Content | LeMaitre Vascular (LMAT) Lags Q2 Earnings Estimates Jul 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 53.24 |
| Today’s open | 53.14 |
| Day’s range | 53.14 - 55.04 |
| Volume | 4,970 |
| Average volume (3 months) | 126,502 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | +21.34% |
| Earnings growth (this year) | -15.70% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +19.37% |
| P/E ratio | 44.3 |
| Price/Sales | 6.99 |
| Price/Book | 4.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRIAtrion Corp | +6.26 | +0.96% |
| CERSCerus Corp | -0.34 | -6.10% |
| AVNSAvanos Medical Inc | -0.27 | -0.94% |
| TMDXTransmedics Group In... | -2.71 | -5.56% |
Data as of 4:00pm ET, 08/08/2022
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | $0.28 |
| Annual revenue (last year) | $154.4M |
| Annual profit (last year) | $26.9M |
| Net profit margin | 17.42% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Burlington, Massachusetts |
Forecasts
